GlassScriptPhysician profile
Kate Belfiore
NPI 1861865313
$4,917.42
in general payments reported to CMS, 2019-2025
36 companies · $1,490 in 2025
The $1,490 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $372 · 2022: $1,036 · 2023: $881 · 2024: $1,140 · 2025: $1,490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,510.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $761.37 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $436.65 | 2021-2025 | Evenity, Repatha, Otezla |
| Lilly USA, LLC | $391.81 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $366.50 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $313.29 | 2022-2025 | Jardiance, Ofev |
| Astrazeneca Pharmaceuticals LP | $231.68 | 2022-2025 | Farxiga, Airsupra |
| Phathom Pharmaceuticals, INC. | $167.01 | 2023-2025 | Voquezna |
| Exact Sciences Corporation | $162.64 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $160.66 | 2022-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $159.49 | 2021-2025 | Xifaxan, Trulance |
| Astellas Pharma US INC | $155.65 | 2021-2025 | Veozah |
| Pfizer INC. | $151.15 | 2021-2025 | |
| Glaxosmithkline, LLC. | $149.09 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $148.41 | 2021-2023 | Xarelto |
| Sumitomo Pharma America, INC. | $98.05 | 2023-2025 | Gemtesa |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kate Belfiore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.